Company Performance - Annaly Capital Management (NLY) experienced a decline of 1.07% in its latest trading session, closing at $22.12, which was a smaller drop compared to the S&P 500's loss of 0.24% [1] - Over the past month, NLY's stock has increased by 4%, outperforming the Finance sector's gain of 3.36% and the S&P 500's gain of 1.31% [1] Upcoming Earnings - The company is expected to report earnings per share (EPS) of $0.72, which remains unchanged from the same quarter last year [2] - Revenue is anticipated to be $469 million, reflecting a significant increase of 150.41% compared to the same quarter last year [2] Annual Forecast - For the entire year, Zacks Consensus Estimates project earnings of $2.9 per share and revenue of $1.24 billion, indicating increases of 7.41% and 399.6%, respectively, from the previous year [3] Analyst Estimates - Recent modifications to analyst estimates for Annaly Capital Management are crucial, as they often reflect changes in short-term business dynamics [4] - Positive estimate revisions are interpreted as favorable indicators for the business outlook [4] Zacks Rank and Valuation - Annaly Capital Management currently holds a Zacks Rank of 3 (Hold), with no changes in the consensus EPS estimate over the past month [6] - The company has a Forward P/E ratio of 7.7, which is lower than the industry average of 8.19, and a PEG ratio of 7, compared to the industry average of 4.77 [7] Industry Context - The REIT and Equity Trust industry, part of the Finance sector, holds a Zacks Industry Rank of 94, placing it in the top 39% of over 250 industries [8] - Research indicates that industries in the top 50% rated by Zacks outperform those in the bottom half by a factor of 2 to 1 [8]

Core Viewpoint - Phillips 66 is experiencing fluctuations in stock performance, with a recent decline of 6.88% while showing a monthly increase of 3.56%, outperforming both the Oils-Energy sector and the S&P 500 [1] Financial Performance - The upcoming financial results for Phillips 66 are anticipated to show an EPS of $2.3, indicating a significant growth of 1633.33% compared to the same quarter last year, despite a projected revenue decline of 11.41% to $30.11 billion [2] - For the full year, earnings are projected at $6.23 per share, with revenue expected to be $130.33 billion, reflecting changes of +1.3% and -10.42% respectively from the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for Phillips 66 are crucial as they reflect short-term business trends, with positive revisions indicating analysts' confidence in the company's performance [4] - The Zacks Rank system, which incorporates these estimate changes, currently ranks Phillips 66 at 3 (Hold), with an upward shift of 8.67% in the consensus EPS estimate over the past month [6] Valuation Metrics - Phillips 66 has a Forward P/E ratio of 22.7, which is higher than the industry average of 14.05, indicating that the company is trading at a premium [7] - The company holds a PEG ratio of 0.74, compared to the industry average of 1.19, suggesting a favorable valuation relative to its projected earnings growth [8] Industry Context - The Oil and Gas - Refining and Marketing industry, to which Phillips 66 belongs, has a Zacks Industry Rank of 85, placing it in the top 35% of over 250 industries, indicating strong performance potential [8][9]

Core Viewpoint - Valero Energy is experiencing a decline in stock performance, with a significant upcoming earnings report expected to show substantial year-over-year growth in earnings per share, despite a projected decline in revenue [2][3]. Group 1: Stock Performance - Valero Energy's stock closed at $162.82, reflecting a -3.03% change from the previous day's closing price, underperforming compared to the S&P 500's loss of 0.24% [1]. - Over the past month, Valero's shares have decreased by 5.89%, which is worse than the Oils-Energy sector's loss of 1.72% and the S&P 500's gain of 1.31% [1]. Group 2: Upcoming Earnings Report - Valero Energy is set to announce its earnings on January 29, 2026, with an expected earnings per share of $3.22, indicating a year-over-year growth of 403.13% [2]. - The consensus estimate for revenue is projected at $29.13 billion, representing a 5.28% decline compared to the same quarter last year [2]. Group 3: Annual Forecasts - For the entire year, the Zacks Consensus Estimates predict earnings of $10.07 per share and revenue of $121.45 billion, reflecting changes of +18.75% and -6.49%, respectively, from the previous year [3]. - Recent analyst estimate revisions suggest a positive outlook for Valero Energy's business and profitability [3][4]. Group 4: Valuation Metrics - Valero Energy currently has a Forward P/E ratio of 16.67, which is higher than the industry average of 14.05, indicating that it is trading at a premium [6]. - The company has a PEG ratio of 1.19, aligning with the industry average, which suggests that the stock's expected earnings growth rate is factored into its valuation [7]. Group 5: Industry Ranking - The Oil and Gas - Refining and Marketing industry, which includes Valero Energy, holds a Zacks Industry Rank of 85, placing it in the top 35% of over 250 industries [7][8]. - The Zacks Industry Rank indicates that the top-rated industries tend to outperform the lower-rated ones by a factor of 2 to 1 [8].

Company Performance - IBM closed at $303.18, reflecting a -1.78% change from the previous day, underperforming the S&P 500's daily loss of 0.24% [1] - Over the past month, IBM shares gained 3.87%, outperforming the Computer and Technology sector's gain of 0.89% and the S&P 500's gain of 1.31% [1] Earnings Expectations - The upcoming earnings report is expected to show an EPS of $4.33, a 10.46% increase compared to the same quarter last year, with projected revenue of $19.21 billion, reflecting a 9.45% rise [2] - For the annual period, earnings are anticipated at $11.39 per share and revenue at $67.02 billion, indicating increases of +10.26% and +6.8% respectively from the previous year [3] Analyst Estimates - Recent changes in analyst estimates for IBM suggest a positive outlook on business operations and profit generation [3] - The Zacks Consensus EPS estimate has increased by 0.04% over the last 30 days, with IBM currently holding a Zacks Rank of 3 (Hold) [5] Valuation Metrics - IBM has a Forward P/E ratio of 27.11, which is a premium compared to the industry average Forward P/E of 24.95 [6] - The PEG ratio for IBM stands at 3.07, while the average PEG ratio for the Computer - Integrated Systems industry is 1.1 [6] Industry Context - The Computer - Integrated Systems industry is part of the Computer and Technology sector, currently holding a Zacks Industry Rank of 15, placing it in the top 7% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]

Core Viewpoint - Exxon Mobil's stock performance has shown a decline recently, with a notable drop compared to the broader market indices, indicating potential investor concerns ahead of its earnings report [1][2]. Company Performance - Exxon Mobil's stock closed at $114.68, reflecting a -2.62% change from the previous day, underperforming the S&P 500's loss of 0.24% [1]. - Over the past month, Exxon Mobil's shares gained 0.07%, outperforming the Oils-Energy sector, which saw a loss of 1.72%, but underperforming the S&P 500's gain of 1.31% [2]. Earnings Projections - The upcoming earnings report is expected to show earnings of $1.63 per share, representing a year-over-year decline of 2.4%, while revenue is projected at $85.13 billion, up 2.05% from the previous year [3]. - Full-year estimates predict earnings of $6.9 per share and revenue of $333.31 billion, indicating year-over-year changes of -11.42% and -4.66%, respectively [4]. Analyst Forecasts - Recent revisions to analyst forecasts for Exxon Mobil are crucial, as they reflect short-term business trends and can influence stock performance [5]. - The Zacks Rank system, which considers estimate changes, currently ranks Exxon Mobil at 3 (Hold), with a recent 0.59% increase in the consensus EPS estimate over the last 30 days [6][7]. Valuation Metrics - Exxon Mobil is trading at a Forward P/E ratio of 17.06, which is higher than the industry average of 10.94, suggesting a premium valuation [8]. - The company has a PEG ratio of 7.42, significantly above the industry average of 1.86, indicating a disparity between its price and anticipated earnings growth [9]. Industry Context - The Oil and Gas - Integrated - International industry, to which Exxon Mobil belongs, has a Zacks Industry Rank of 161, placing it in the bottom 35% of over 250 industries, which may affect overall investor sentiment [10].

Company Performance - Abbott's stock closed at $128.47, reflecting a +2.4% change from the previous day's closing price, outperforming the S&P 500's loss of 0.16% [1] - Over the past month, Abbott's shares have decreased by 3.93%, underperforming the Medical sector's gain of 1.12% and the S&P 500's loss of 0.21% [1] Upcoming Financial Results - Abbott's upcoming EPS is projected at $1.5, indicating an 11.94% increase compared to the same quarter of the previous year [2] - Revenue is expected to reach $11.79 billion, representing a 7.48% growth compared to the corresponding quarter of the prior year [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $5.15 per share and revenue at $44.6 billion, reflecting changes of +10.28% and +6.33% respectively from the prior year [3] Analyst Estimates - Recent adjustments to analyst estimates for Abbott are important as they indicate changing near-term business trends, with upward revisions suggesting analysts' positivity towards the company's operations [4] - The consensus EPS projection has remained stable over the past 30 days, and Abbott currently holds a Zacks Rank of 3 (Hold) [6] Valuation Metrics - Abbott's Forward P/E ratio is 24.37, which is a premium compared to the industry average Forward P/E of 19.3 [6] - The company has a PEG ratio of 2.29, while the average PEG ratio for Medical - Products stocks is 1.92 [7] Industry Context - The Medical - Products industry, part of the Medical sector, has a Zacks Industry Rank of 165, placing it in the bottom 34% of over 250 industries [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - PepsiCo's stock increased by 1.08% to $150.65, outperforming the S&P 500's decline of 1.07% [1] - Over the past month, PepsiCo shares gained 2.77%, while the Consumer Staples sector experienced a loss of 0.24% [1] Upcoming Earnings - The upcoming earnings release is anticipated, with an expected EPS of $2.24, representing a 14.29% increase from the same quarter last year [2] - Revenue is projected at $28.84 billion, reflecting a 3.79% rise from the equivalent quarter last year [2] Full Year Projections - For the full year, earnings are estimated at $8.11 per share, a decrease of 0.61% from the previous year, while revenue is projected at $93.54 billion, an increase of 1.84% [3] - Analysts' forecast revisions are crucial as they indicate changing business trends, with positive revisions suggesting optimism about profitability [3] Valuation Metrics - PepsiCo has a Forward P/E ratio of 18.38, slightly above the industry average of 18.35, indicating a premium valuation [6] - The PEG ratio for PepsiCo stands at 5.15, compared to the industry average of 2.18, suggesting higher projected earnings growth expectations [6] Industry Context - The Beverages - Soft drinks industry is part of the Consumer Staples sector and currently holds a Zacks Industry Rank of 161, placing it in the bottom 35% of over 250 industries [7] - The Zacks Industry Rank evaluates industry strength based on the average Zacks Rank of individual stocks, with top-rated industries outperforming lower-rated ones by a factor of 2 to 1 [7]

Core Viewpoint - Sirius XM is experiencing a mixed performance in the market, with a recent decline in share price and upcoming earnings release that is anticipated to show a year-over-year decline in earnings and revenue [1][2]. Financial Performance - Analysts expect Sirius XM to report earnings of $0.77 per share, reflecting a year-over-year decline of 7.23% [2]. - The revenue forecast for the upcoming quarter is $2.17 billion, indicating a 0.6% drop compared to the same quarter last year [2]. - For the entire fiscal year, earnings are projected at $2.77 per share, representing a significant increase of 55.62%, while revenue is expected to be $8.54 billion, showing a decline of 1.83% from the previous year [3]. Analyst Sentiment - Recent revisions to analyst forecasts for Sirius XM are crucial as they reflect the changing dynamics of the business [4]. - Positive revisions in estimates are seen as a sign of analysts' confidence in the company's performance and profit potential [4][5]. Valuation Metrics - Sirius XM has a Forward P/E ratio of 8.05, which is significantly lower than the industry average of 15.83, indicating that the company is trading at a discount [7]. - The company also holds a PEG ratio of 0.34, compared to the industry average PEG ratio of 1.33, suggesting favorable growth prospects relative to its valuation [8]. Industry Context - The Broadcast Radio and Television industry, which includes Sirius XM, is currently ranked 166 in the Zacks Industry Rank, placing it in the bottom 33% of over 250 industries [9]. - The Zacks Industry Rank indicates that industries in the top 50% tend to outperform those in the bottom half by a factor of 2 to 1 [9].

Company Performance - Archer Daniels Midland (ADM) stock increased by 2.94% to $59.92, outperforming the S&P 500 which gained 0.21% [1] - Over the last month, ADM shares rose by 0.8%, lagging behind the Consumer Staples sector's gain of 1% and the S&P 500's gain of 0.89% [1] Upcoming Financial Results - The upcoming EPS for ADM is projected at $0.85, indicating a 25.44% decline compared to the same quarter last year [2] - Revenue is expected to reach $22.14 billion, reflecting a 2.98% increase from the year-ago quarter [2] Fiscal Year Projections - For the entire fiscal year, earnings are projected at $3.41 per share, representing a decrease of 28.06% from the previous year [3] - Revenue for the fiscal year is estimated at $83.85 billion, showing a decline of 1.96% compared to the prior year [3] Analyst Estimates - Recent changes to analyst estimates for ADM indicate shifting business dynamics, with upward revisions suggesting positive sentiment towards the company's operations [4] - The Zacks Rank system, which assesses these estimates, currently rates ADM as a 5 (Strong Sell) [6] Valuation Metrics - ADM has a Forward P/E ratio of 17.09, which is in line with the industry average [7] - The PEG ratio for ADM is 4.94, significantly higher than the Agriculture - Operations industry average of 2.14 [7] Industry Context - The Agriculture - Operations industry, part of the Consumer Staples sector, ranks in the bottom 19% of all industries according to the Zacks Industry Rank [8] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [8]

Company Performance - Boston Scientific's stock was down 1.02% at $91.75, underperforming the S&P 500's daily gain of 0.21% and the Dow's increase of 1.35% [1] - Over the past month, shares of Boston Scientific have decreased by 10.98%, contrasting with the Medical sector's gain of 3.7% and the S&P 500's gain of 0.89% [1] Upcoming Earnings - Analysts expect Boston Scientific to report earnings of $0.78 per share, indicating a year-over-year growth of 11.43% [2] - The consensus estimate projects revenue of $5.27 billion, reflecting a 15.46% increase from the same quarter last year [2] Annual Estimates - For the annual period, earnings are anticipated to be $3.04 per share and revenue is expected to reach $20.06 billion, representing increases of 21.12% and 19.77% respectively from the previous year [3] - Recent adjustments to analyst estimates suggest a favorable outlook on Boston Scientific's business health and profitability [3] Valuation Metrics - Boston Scientific is currently trading at a Forward P/E ratio of 30.54, which is higher than the industry average of 19.41, indicating a premium valuation [6] - The company has a PEG ratio of 1.87, compared to the industry average PEG ratio of 1.95 [7] Industry Ranking - The Medical - Products industry, which includes Boston Scientific, has a Zacks Industry Rank of 165, placing it within the bottom 34% of over 250 industries [8] - The Zacks Industry Rank evaluates the performance of industry groups based on the average Zacks Rank of individual stocks, with the top 50% rated industries outperforming the bottom half by a factor of 2 to 1 [8]